287 related articles for article (PubMed ID: 19549585)
21. HIV-1 drug resistance in variants from the female genital tract and plasma.
Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
[TBL] [Abstract][Full Text] [Related]
22. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil.
Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA
J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.
Torti C; Bono L; Gargiulo F; Uccelli MC; Quiros-Roldan E; Patroni A; Paraninfo G; Tirelli V; Manca N; De Francesco MA; Perandin F; Carosi G
Clin Microbiol Infect; 2004 Sep; 10(9):826-30. PubMed ID: 15355414
[TBL] [Abstract][Full Text] [Related]
24. Sustained appearance of drug resistance-associated mutations in HIV-1 CRF01_AE protease and reverse transcriptase derived from protease inhibitor-naive Thai patients.
Jullaksorn D; Boonchawalit S; Uttiyoung J; Soonthornsata B; Yowang A; Krathong N; Chautrakul S; Ikuta K; Roobsoong A; Kanitvittaya S; Sawanpanyalert P; Kameoka M
Southeast Asian J Trop Med Public Health; 2010 Mar; 41(2):347-57. PubMed ID: 20578518
[TBL] [Abstract][Full Text] [Related]
25. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
26. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
[TBL] [Abstract][Full Text] [Related]
27. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
28. Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.
Paraschiv S; Otelea D; Baicus C; Tinischi M; Costache M; Neaga E
Int J Infect Dis; 2009 Jan; 13(1):81-9. PubMed ID: 18632295
[TBL] [Abstract][Full Text] [Related]
29. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
[TBL] [Abstract][Full Text] [Related]
30. Drug resistance mutations in patients infected with HIV-2 living in Spain.
Treviño A; de Mendoza C; Caballero E; Rodríguez C; Parra P; Benito R; Cabezas T; Roc L; Aguilera A; Soriano V;
J Antimicrob Chemother; 2011 Jul; 66(7):1484-8. PubMed ID: 21558334
[TBL] [Abstract][Full Text] [Related]
31. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.
Rodrigues R; Scherer LC; Oliveira CM; Franco HM; Sperhacke RD; Ferreira JL; Castro SM; Stella IM; Brigido LF
Virus Res; 2006 Mar; 116(1-2):201-7. PubMed ID: 16332398
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.
Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Pérez-Alvarez L; Pumarola T; López-Lirola A; González-García J; Menéndez-Arias L;
J Antimicrob Chemother; 2009 Aug; 64(2):251-8. PubMed ID: 19505892
[TBL] [Abstract][Full Text] [Related]
33. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
35. Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naïve patients in Accra, Ghana.
Sagoe KW; Dwidar M; Lartey M; Boamah I; Agyei AA; Hayford AA; Mingle JA; Arens MQ
J Clin Virol; 2007 Oct; 40(2):163-7. PubMed ID: 17827059
[TBL] [Abstract][Full Text] [Related]
36. Lack of high-level resistance mutations in HIV type 1 BF recombinant strains circulating in northeast Brazil.
Monteiro-Cunha JP; Araujo AF; Santos E; Galvao-Castro B; Alcantara LC
AIDS Res Hum Retroviruses; 2011 Jun; 27(6):623-31. PubMed ID: 21087197
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
[TBL] [Abstract][Full Text] [Related]
38. Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study.
Mousavi SM; Hamkar R; Gouya MM; Safaie A; Zahraei SM; Yazdani Z; Asbaghi Namini S; Bertagnolio S; Sutherland D; Sandstrom P; Brooks J
Arch Virol; 2010 Mar; 155(3):329-34. PubMed ID: 20052598
[TBL] [Abstract][Full Text] [Related]
39. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
[TBL] [Abstract][Full Text] [Related]
40. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
